650 results on '"Verkooijen, Helena M"'
Search Results
2. Quality of life of women with a screen-detected versus clinically detected breast cancer in the Netherlands: a prospective cohort study
3. Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost
4. The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide Analysis
5. Tablet, Web-Based, or Paper Questionnaires for Measuring Anxiety in Patients Suspected of Breast Cancer: Patients' Preferences and Quality of Collected Data
6. Preoperative Magnetic Resonance Guided Single-Dose Partial Breast Irradiation: 5-Year Results of the Prospective Single-Arm ABLATIVE Trial
7. Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping review
8. On Patient Experience and Anxiety During Treatment With Magnetic Resonance–Guided Radiation Therapy
9. Risk Factors for Unplanned Reoperation during the Expansion Phase in Two-Stage Breast Reconstruction in the Dutch Breast Implant Registry
10. MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study
11. Physical and mental health of breast cancer patients and survivors before and during successive SARS-CoV-2-infection waves
12. Breast cancer patients’ needs and perspectives on a one-on-one peer support program: quantitative and qualitative analyses
13. Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study
14. Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer
15. Magnetic Resonance-Guided Adaptive Radiation Therapy for Prostate Cancer: The First Results from the MOMENTUM study—An International Registry for the Evidence-Based Introduction of Magnetic Resonance-Guided Adaptive Radiation Therapy
16. Patient Expectations About Palliative Treatment for Symptomatic Spinal Metastases: A Qualitative Study
17. The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer
18. Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer
19. Risk factors for unplanned reoperation during the expansion phase in two-stage breast reconstruction in the Dutch Breast Implant Registry
20. Implementation of Magnetic Resonance Imaging-Guided Radiation Therapy in Routine Care: Opportunities and Challenges in the United States
21. Most patients reported positively or neutrally of having served as controls in the trials within cohorts design
22. Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma
23. Dynamic Contrast-enhanced and Diffusion-weighted Magnetic Resonance Imaging for Response Evaluation After Single-Dose Ablative Neoadjuvant Partial Breast Irradiation
24. Urethral and bladder dose–effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial
25. Translation and validation of the Dutch Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) to evaluate health-related quality of life in patients with symptomatic spinal metastases
26. Focused Ultrasound and RadioTHERapy for non-invasive palliative pain treatment in patients with bone metastasis: a study protocol for the three armed randomized controlled FURTHER trial
27. The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer
28. Coronary artery calcifications on breast cancer radiotherapy planning CT scans and cardiovascular risk: What do patients want to know?
29. Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients
30. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic
31. Anorectal dose–effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial
32. Early health economic analysis of 1.5 T MRI-guided radiotherapy for localized prostate cancer: Decision analytic modelling
33. Effects of exercise in breast cancer patients: implications of the trials within cohorts (TwiCs) design in the UMBRELLA Fit trial
34. The impact of hyperbaric oxygen therapy on late radiation toxicity and quality of life in breast cancer patients
35. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens
36. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters
37. Combining radiotherapy and focused ultrasound for pain palliation of cancer induced bone pain; a stage I/IIa study according to the IDEAL framework
38. Oncology patients were found to understand and accept the Trials within Cohorts design
39. Consensus on Contouring Primary Breast Tumors on MRI in the Setting of Neoadjuvant Partial Breast Irradiation in Trials
40. The trials within cohorts design facilitated efficient patient enrollment and generalizability in oncology setting
41. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial
42. Alternative Randomized Trial Designs in Surgery: A Systematic Review
43. Correction to: Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer
44. ASO Visual Abstract: Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer
45. The importance of timely treatment for quality of life and survival in patients with symptomatic spinal metastases
46. Expectations of treatment outcomes in patients with spinal metastases; what do we tell our patients? A qualitative study
47. Delayed presentation to a spine surgeon is the strongest predictor of poor postoperative outcome in patients surgically treated for symptomatic spinal metastases
48. The Trials within Cohorts design faced methodological advantages and disadvantages in the exercise oncology setting
49. External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible but Nonrandomized Patients
50. Impact of modern-day axillary treatment on patient reported arm morbidity and physical functioning in breast cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.